Summary & Overview
CPT 81443: Genetic Testing Panel for Severe Inherited Conditions
CPT code 81443 represents a comprehensive genetic testing panel for severe inherited conditions, including cystic fibrosis, Ashkenazi Jewish‑associated disorders, beta hemoglobinopathies, phenylketonuria, and galactosemia. This code is significant nationally as it enables early detection and diagnosis of a wide range of genetic disorders, supporting clinical decision-making and patient management. The panel requires sequencing of at least 15 genes, ensuring broad coverage for conditions with complex genetic backgrounds.
Major payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, and UnitedHealthcare. The publication provides insights into payer coverage policies, billing benchmarks, and recent policy updates relevant to molecular pathology and genomic sequencing services. Readers will gain an understanding of the clinical context for CPT 81443, including its role in genetic screening and the types of conditions it addresses. The summary also highlights common billing practices and the importance of accurate coding for reimbursement.
This article is designed for healthcare professionals, billing specialists, and policy analysts seeking up-to-date information on genetic testing codes, payer coverage, and evolving trends in molecular diagnostics. It offers a clear overview of the code's clinical applications, payer landscape, and key considerations for billing and compliance.
CPT Code Overview
CPT 81443 is used for genetic testing targeting severe inherited conditions, including disorders such as cystic fibrosis, Ashkenazi Jewish‑associated syndromes (for example, Bloom syndrome, Canavan disease, Fanconi anemia type C, mucolipidosis type VI, Gaucher disease, Tay‑Sachs disease), beta hemoglobinopathies, phenylketonuria, and galactosemia. This code covers a genomic sequence analysis panel that must include sequencing of at least 15 genes, such as ACADM, ARSA, ASPA, ATP7B, BCKDHA, BCKDHB, BLM, CFTR, DHCR7, FANCC, G6PC, GAA, GALT, GBA, GBE1, HBB, HEXA, IKBKAP, MCOLN1, and PAH.
Service type: Molecular pathology / Genomic sequencing.
Typical site of service: Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A patient with a family history of severe inherited conditions, such as cystic fibrosis or Ashkenazi Jewish-associated disorders, presents for genetic counseling. The clinician orders a comprehensive genomic sequencing panel to assess the risk of inherited diseases. The workflow involves collecting a blood or saliva sample, sending it to a molecular pathology laboratory, and performing sequencing of at least 15 genes relevant to severe inherited conditions. Results are reviewed by a geneticist or molecular pathologist and discussed with the patient and their family.
Coding Specifications
-
Modifier
GX: Used when a Voluntary Advance Beneficiary Notice of Noncoverage (ABN) is issued, indicating that Medicare will likely deny coverage for the service. -
Modifier
GY: Used when a Notice of Exclusion is issued, indicating that the service is statutorily excluded from Medicare coverage.
| Modifier Code | Description |
|---|---|
GX | Voluntary ABN issued — Medicare will likely deny |